Partners4Access

Partners4Access (P4A), the specialists in orphan drug access, are launching a new webinar series, in line with their expanding activities in gene therapy.

Partners4Access launch an innovative Professional Access Coaching for Excellence Service

Partners4Access (P4A) the specialists in orphan drug access, has appointed two new analysts to their European team, in line with their expanding activities in gene therapy.

Partners4Access will attend the Festival of Genomics in Boston on October 3rd, 2017. Sophie Schmitz, Managing Partner at P4A will be there meeting representatives of the research and patient community as well as the pharmaceutical industry.

Partners4Access Managing Partner Sophie Schmitz attended the World Orphan Drug Congress in Washington and reports insights from the Glybera case.

London team strengthened to drive further launch support for the biotechnology industry. Continued focus is 'Orphan Drug Solutions' a partnership approach to ensuring a successful global launch.